Published in Obstet Gynecol on April 01, 1985
An approach to the patient with urticaria. Clin Exp Immunol (2008) 1.13
Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther (2006) 0.90
Anticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in Mice. Iran J Med Sci (2013) 0.86
Are probiotics safe for use during pregnancy and lactation? Can Fam Physician (2011) 0.83
Assessment of antihistamine use in early pregnancy and birth defects. J Allergy Clin Immunol Pract (2013) 0.81
Treating constipation during pregnancy. Can Fam Physician (2012) 0.78
Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol (2013) 0.77
Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol (2013) 0.77
Treating the common cold during pregnancy. Can Fam Physician (2008) 0.76
Prenatal paracetamol exposure is associated with shorter anogenital distance in male infants. Hum Reprod (2016) 0.76
Antihistamines and birth defects: a systematic review of the literature. Expert Opin Drug Saf (2014) 0.75
Risk factors and demographics for microtia in South America: a case-control analysis. Birth Defects Res A Clin Mol Teratol (2013) 0.75
Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies. Can Fam Physician (1991) 0.75
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Teratogenicity of high vitamin A intake. N Engl J Med (1995) 5.53
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Antidepressants and suicide. BMJ (1995) 4.84
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Evaluation of smoking prohibition policy in a health maintenance organization. Am J Public Health (1986) 4.08
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Prenatal genetic diagnosis. I. N Engl J Med (1970) 3.67
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Maternal serum AFP secreening. N Engl J Med (1978) 3.17
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Comprehensive drug surveillance. JAMA (1970) 2.92
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Threatened survival of academic-based genetic laboratory services. Am J Hum Genet (1992) 2.65
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature (1992) 2.63
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Prenatal genetic diagnosis (second of three parts). N Engl J Med (1970) 2.29
Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. Obstet Gynecol (1977) 2.24
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA (1992) 2.11
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Methotrexate-induced congenital malformations. J Pediatr (1968) 2.00
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA (1984) 1.82
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
Duty to re-contact. Genet Med (2001) 1.80
The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics (1998) 1.79
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet (1993) 1.64
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Growth of Streptococcus mutans in a chemostat. Arch Oral Biol (1974) 1.61
The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care (1990) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
Agenesis or hypoplasia of major salivary and lacrimal glands. Am J Med Genet (1990) 1.57
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Drug-related deaths among medical inpatients. JAMA (1977) 1.53
Failure of amniotic-fluid cell growth with toxic tubes. N Engl J Med (1979) 1.52
Testicular cancer in the United States: trends in incidence and mortality. Int J Epidemiol (1986) 1.52
Diuretic drug use and the risk for hip fracture. Ann Intern Med (1991) 1.52
Magnesium-limited growth of Aerobacter aerogenes in a chemostat. J Gen Microbiol (1965) 1.46
First trimester topical tretinoin and congenital disorders. Lancet (1993) 1.45
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1978) 1.45
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA (1986) 1.45
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
The influence of temperature and pH value on the macro-molecular composition of magnesium-limited and glycerol-limited Aerobacter aerogenes growing in a chemostat. J Gen Microbiol (1965) 1.43
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol (1994) 1.41
Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol (1992) 1.40
Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol (1984) 1.38
Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy (2000) 1.38
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol (1993) 1.37
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (1998) 1.36
Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis (1982) 1.35
Cholestatic hepatitis associated with flucloxacillin. Med J Aust (1993) 1.34
First-trimester drug use and congenital disorders. JAMA (1981) 1.34
Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet (1977) 1.33
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology (2000) 1.29
Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol (1996) 1.28